INHIBIN AS A TUMOR MARKER OF OVARIAN CANCER IN POSTMENOPAUSAL WOMEN

Q: How can I download an article?

To download an article from SID, first log in to the site, search for the article title, and click on the 'Download Article' option.

Q: How can I download an ISI article?

To download an ISI article on SID, enter the keyword or article title in the search bar, view the relevant results, click on the desired article, and select the 'Download Article' option.

Q: How can I access the SID database?

To access the SID database, visit SID.ir, create an account, and log in to access scientific resources.

Q: Is downloading articles from SID free?

Some articles on SID are available for free, while others require payment. Details are specified on the article's page.

MODARRES GILANI MITRA; KARIMI MAHSHID

مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Journal Paper

Paper Information

Journal: Tehran University Medical Journal Year:2010 | Volume:68 | Issue:2 Page(s): 116-119

Download Full-Text

Persian Verion

View:

1,407

Download:

Cites:

Information Journal Paper

Title

INHIBIN AS A TUMOR MARKER OF OVARIAN CANCER IN POSTMENOPAUSAL WOMEN

Author(s)

MODARRES GILANI MITRA | KARIMI MAHSHID | Issue Writer Certificate

Keywords

INHIBINQ3

TUMOR MARKERQ3

OVARIAN CANCERQ2

Abstract

Background: INHIBIN is a dimeric glycoprotein that has a depressive effect on the anterior hypophys secretion. The level of this TUMOR MARKER is undetectable in menopause women. In patients with gynecological cancer, especially granulosa and epidermal-type (mucinous), OVARIAN CANCERs considerable increase in the serum level of INHIBIN has been reported. The increased level of INHIBIN has been reported in patients with recurrent OVARIAN CANCER.Methods: We measured total serum INHIBIN and CA125 TUMOR MARKER level in 38 postmenopausal women with pathologically confirmed OVARIAN CANCER before and after surgery out of 51 suspected women. Our control group were postmenopausal women that attended to our clinic for routine gynecologic check up. Both TUMOR MARKERs were measured in these patients too.Results: Among 38 women with OVARIAN CANCER, 13 (34.2%) had elevated serum levels of total INHIBIN. Among the 16 women with serous adenocarcinoma, 3 patients (18.8%) had elevated serum levels of INHIBIN. All the three women with granulosa cell tumor had elevated serum levels of INHIBIN (100%) and 3 of 4 (75%) women with mucinous OVARIAN CANCER had the same result. three out of 38 women in control group had elevated serum levels of INHIBIN. Among all 38 patients, 6 (15.7%) showed tumor recurrence, that all were concomitant with rising of both serum CA125 and INHIBIN levels (p=0/001).Conclusions: Serum INHIBIN level is a usefull TUMOR MARKER in granulosa cell and in mucinous tumor of ovary. In this study combined INHIBIN and CA125 assay showed better results in early detection of OVARIAN CANCER in comparison to either CA125 or INHIBIN alone.

Cites

No record.

References

No record.

Cite

APA: Copy

MODARRES GILANI, MITRA, & KARIMI, MAHSHID. (2010). INHIBIN AS A TUMOR MARKER OF OVARIAN CANCER IN POSTMENOPAUSAL WOMEN. TEHRAN UNIVERSITY MEDICAL JOURNAL (TUMJ), 68(2), 116-119. SID. https://sid.ir/paper/38500/en

Vancouver: Copy

MODARRES GILANI MITRA, KARIMI MAHSHID. INHIBIN AS A TUMOR MARKER OF OVARIAN CANCER IN POSTMENOPAUSAL WOMEN. TEHRAN UNIVERSITY MEDICAL JOURNAL (TUMJ)[Internet]. 2010;68(2):116-119. Available from: https://sid.ir/paper/38500/en

IEEE: Copy

MITRA MODARRES GILANI, and MAHSHID KARIMI, “INHIBIN AS A TUMOR MARKER OF OVARIAN CANCER IN POSTMENOPAUSAL WOMEN,” TEHRAN UNIVERSITY MEDICAL JOURNAL (TUMJ), vol. 68, no. 2, pp. 116–119, 2010, [Online]. Available: https://sid.ir/paper/38500/en

Related Journal Papers